Cypress Reports on Dean Lithium Claystone Solubility

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
56
Cypress Reports on Dean Lithium Claystone Solubility Results in Clayton Valley, Nevada

VANCOUVER, British Columbia, Jan. 12, 2017 (GLOBE NEWSWIRE) -- Cypress Development Corp. (TSX-V: CYP ) (OTCBB: CYDVF ) (Frankfurt: C1Z1 ) (“Cypress” or the “Company”) is pleased to announce that the Company has received solubility study assay results from Cypress’ 2,700 acre Dean Lithium Brine/Claystone Project located in the heart of the Clayton Valley lithium exploration area of Esmeralda county, Nevada.

Cypress Clayton Valley Lithium Project, Nevada location map: http://www.cypressdevelopmentcorp.com/i/maps/...-small.jpg

The Company's Dean Project is located adjacent to producing lithium brine wells belonging to the Albemarle Silver Peak mine on its west boundary, Pure Energy's resource area on its southwest boundary and Cypress' Glory Project, optioned to Pure Energy, on its southern boundary.

Highlights:

  • Cypress completes solubility studies on 48 previously assayed Dean claystone samples;
  • A deionized water leach process returns 36.15% Li recovery on average;
  • A modified dilute acid leach process returns 94.72% Li recovery on average;
  • Permit application made to BLM, Nevada for a series of drill holes into new Frontera Verda Zone;
  • Cypress anticipates drilling to begin at the end of January.

September and October 2016 surface sampling on the Dean Project has revealed a 2 square kilometer area of strong lithium mineralization up to 3,700 ppm Li (0.82% Li20 equivalent) in calcareous, volcanoclastic, claystones, mudstones and volcanic ash units. The mineralization is essentially identical to the acreage being jointly explored by Cypress and Pure Energy Minerals on Cypress’ Glory Project immediately to the south.

Dean sample locations and assay values map: http://www.cypressdevelopmentcorp.com/i/maps/...-Nov16.jpg

Cypress has now completed solubility studies with 48 previously assayed claystone samples from the Dean property. A modified dilute Aqua Regia (dilute acid) process (ME-MS41W) and a deionized water leach process (ME-MS03) has been carried out by ALS/Chemex lab in Reno, Nevada in order to provide Cypress with further data on the potential feasibility of a large-scale leach extraction method of lithium from the abundant mineralized claystone.

The additional assay procedures recently carried out on the samples by ALS/Chemex from the Dean property clearly show that the lithium in the uplifted exposed lake bed sediments is easily leached by a dilute acid solution and deionized water process.

Dean Lithium Solubility Study Assay Results:

Sample   *ME- ICP61 Li ppm   *ME- MS41W Li ppm   *ME- MS03 Li ppm % Li Recovery with Dilute Aqua Regia % Li Recovery with Deionized Water
Dean-1   1010   1010   105   100.00 %   10.40 %
Dean-2   1770   1720   1100   97.18 %   62.15 %
Dean-3   1480   1500   302   101.35 %   20.41 %
Dean-4   1250   1240   122   99.20 %   9.76 %
Dean-5   930   910   164   97.85 %   17.63 %
Dean-6   1130   1070   124   94.69 %   10.97 %
Dean-7   1560   1520   832   97.44 %   53.33 %
Dean-8   1720   1640   854   95.35 %   49.65 %
Dean-9   2090   1990   1100   95.22 %   52.63 %
Dean-10   830   790   195   95.18 %   23.49 %
Dean-22   790   750   239   94.94 %   30.25 %
Dean-24   2940   2780   1100   94.56 %   37.41 %
Dean-25   950   880   528   92.63 %   55.58 %
Dean-26   640   560   188   87.50 %   29.38 %
Dean-27   900   880   125   97.78 %   13.83 %
Dean-28   1350   1340   247   99.26 %   18.30 %
Dean-29   960   920   190   95.83 %   19.74 %
Dean-30   510   480   103   94.12 %   20.20 %
Dean-31   350   348   111   99.43 %   31.71 %
Dean-32   960   940   70   97.92 %   7.28 %
Dean-33   1440   1420   279   98.61 %   19.38 %
Dean-41   1100   1020   826   92.73 %   75.09 %
Dean-42   1030   970   634   94.17 %   61.55 %
Dean-43   1000   920   237   92.00 %   23.70 %
Dean-44   1890   1840   590   97.35 %   31.22 %
Dean-45   360   298   54   82.78 %   15.11 %
Dean-46   650   590   510   90.77 %   78.46 %
Dean-47   910   850   487   93.41 %   53.52 %
Dean-48   670   550   229   82.09 %   34.18 %
Dean-49   1100   1040   104   94.55 %   9.41 %
Dean-50   1250   1120   865   89.60 %   69.20 %
Dean-51   1020   960   155   94.12 %   15.15 %
Dean-52   1380   1400   1100   101.45 %   79.71 %
Dean-53   1200   1140   978   95.00 %   81.50 %
RKCV-00810   1480   1390   553   93.92 %   37.36 %
RKCV-00811   1320   1270   273   96.21 %   20.68 %
RKCV-00812   1750   1820   1100   104.00 %   62.86 %
RKCV-00813   2130   2040   1100   95.77 %   51.64 %
RKCV-00814   1000   980   298   98.00 %   29.80 %
RKCV-00815   390   369   108.5   94.62 %   27.82 %
RKCV-00816   780   690   280   88.46 %   35.90 %
RKCV-00817   780   730   278   93.59 %   35.64 %
RKCV-00818   1640   1560   790   95.12 %   48.17 %
RKCV-00819   1450   1400   618   96.55 %   42.62 %
RKCV-00820   800   760   279   95.00 %   34.88 %
RKCV-00821   1150   1050   567   91.30 %   49.30 %
RKCV-00822   810   780   157   96.30 %   19.38 %
RKCV-00823   570   500   196   87.72 %   34.39 %
              94.72% AV 36.15% AV

* ME-ICP61 is a 4 acid digestion that will extract lithium from any mineral including silicates * ME-MS41W is a highly dilute version of Aqua Regia that will dissolve carbonate minerals * ME-MS03 is a leach method that uses deionized water to extract lithium in the sample * Li = Lithium Metal * ppm = parts per million * AV = Average

Several first order drill targets have been defined on the Dean property that include extensive outcropping of altered green evaporate-rich volcanoclastic claystone / mudstone exposures known as the Frontera Verde Zone. The Frontera Verde Zone covers an area of greater than 2 square kilometers. The average lithium grade of the Frontera Verde Zone is greater than 1500 ppm Li (>0.32% Li2O).

Outcropping lithium-rich mudstones at Dean Project: http://www.cypressdevelopmentcorp.com/i/maps/...-South.jpg

Donald Huston, President Cypress Development, stated,  "The results generated from the most recent assays consisting of a highly dilute weak Aqua Regia solution and a deionized water solution on the Dean Project samples has returned very encouraging results relating to the lithium recovery from the claystone that is known to exist on the majority of the Dean Project in Clayton Valley, Nevada. It is evident that the use of differing solutions in the assay procedure, as noted above, that the abundant lithium-rich claystone could be amenable to an extraction methodology that could be cost effective with a very high recovery of lithium content expected from processing. Cypress’ management are very encouraged with the progress seen to date and will continue with work on potential lithium extraction methods from the claystone.”

All Data compiled by Cypress to date indicates that a readily soluble non-hectorite mineral form of lithium-rich claystone exists at surface over wide areas of Cypress’ Glory and Dean Clayton Valley projects.

Cypress has made application to the BLM, Nevada for an area of disturbance Permit to allow for a series of drill holes into the new Frontera Verda Zone on the Dean Project. The Company anticipates mobilizing a drill crew into the Clayton Valley by the end of January.

Quality Control and Quality Assurance:

All samples were submitted to ALS Chemex Labs in Reno, Nevada for analysis using a modified weak Aqua Regia (dilute acid) process (ME-MS41W) and a deionized water leach process (ME-MS03). Blind sample blanks were inserted into the sample sequences at a rate of approximately 1 per 20 samples.

Robert Marvin, PGeo, Exploration Manager for Cypress Development Corp., is the qualified person as defined by National Instrument 43-101 and has approved of the technical information in this release.

About Cypress Development Corp.:

Cypress development Corp is a publicly traded lithium and zinc exploration company that continues to acquire and develop potentially viable mineral projects in the State of Nevada, U.S.A.

Cypress is very active in Clayton Valley, Nevada with its team committed to systematically exploring its properties for both a lithium-brine resource and expanding exploration relating to the potential for a lithium resource that exists within the large area of non-hectorite “claystones” discovered at surface that has seen recent high lithium assays recovered from these same “claystones”.

Cypress Development Corp. has approx. 33.4 million shares issued and outstanding.

To find out more about Cypress Development Corp. (TSX-V: CYP ), visit our website at www.cypressdevelopmentcorp.com .

CYPRESS DEVELOPMENT CORP.

“Don Huston”                                                             DONALD C. HUSTON President

For further information contact myself or: Don Myers Director Cypress Development Corp. Telephone: 604-687-3376 Toll Free: 800-567-8181 Facsimile: 604-687-3119 Email: info@cypressdevelopmentcorp.com

NEITHER THE TSX VENTURE EXCHANGE NOR ITS REGULATION SERVICES PROVIDER ACCEPTS RESPONSIBILITY FOR THE ADEQUACY OR ACCURACY OF THE CONTENT OF THIS NEWS RELEASE.

This release includes certain statements that may be deemed to be "forward-looking statements". All statements in this release, other than statements of historical facts, that address events or developments that management of the Company expects, are forward-looking statements. Although management believes the expectations expressed in such forward-looking statements are based on reasonable assumptions, such statements are not guarantees of future performance, and actual results or developments may differ materially from those in the forward-looking statements. The Company undertakes no obligation to update these forward-looking statements if management's beliefs, estimates or opinions, or other factors, should change. Factors that could cause actual results to differ materially from those in forward-looking statements, include market prices, exploration and development successes, continued availability of capital and financing, and general economic, market or business conditions. Please see the public filings of the Company at www.sedar.com for further information.

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Surfing Dogs Ride Waves, Support Orphan Pets

Updated Category News Views 2

Waves, Paws, and Passion Who would've thought that dogs catching waves could also catch hearts and wallets? Well, that's exactly what's happening today at Del Mar Dog Beach with the 21st Annual Surf Dog Surf-A-Thon revving up the excitement. It's a sun-soaked day in Rancho Santa Fe, California, right in the thick of things at the longest-running dog surf competition. For...

Continue Reading
PANDAG G1 Debuts: Revolutionizing Lawn Care Efficiency

Updated Category News Views 4

The Future of Landscaping Unveiled Get this—PANDAG is set to shake things up at GaLaBau 2026 with their futuristic G1 autonomous mower. This isn't just another piece of lawn equipment; it's practically a tech marvel on wheels, weaving together LiDAR, AI Vision, RTK, and 4G tech to make it the ultimate multitasker for the landscaping industry. We're talking obstacle...

Continue Reading
First-Time Homeowners: Unseen Pitfalls of Insurance

Updated Category News Views 0

Understanding Homeowners Insurance: Beyond the Basics Most folks diving into homeownership for the first time get caught up in the whirlwind of price tags, loans, and knick-knacks for their new place. Meanwhile, the nitty-gritty of homeowners insurance often gets tossed to the side. But take it from a weary watchdog of financial storms—it’s those details in the policy...

Continue Reading
GORGIE Unleashes Berry Burst: Target's New Drink Star

Updated Category News Views 2

GORGIE Targets Taste Buds with Berry Burst Ever feel like you're missing out on that energy drink everyone seems to be raving about? Well, GORGIE's out there making some noise again, and this time it's got a new punchy player in the game: Berry Burst. It's not just another drink; it's shaking things up in the energy aisle with its exclusive launch at Target. Modern style...

Continue Reading
Tam-Peli Steps Up in SCLC Battle: Trial Insights

Updated Category News Views 5

Noteworthy Developments in Small-Cell Lung Cancer Treatment Let's dive into a story straight from the world of small-cell lung cancer (SCLC) that doesn't take any prisoners. The antidote making waves is tambotatug pelitecan, or Tam-Peli for short, showcasing its might in the unrelenting fight against relapsed SCLC. The phase III TAISHAN-302 trial puts Tam-Peli...

Continue Reading
Trial Disappointment: No Significant Gains in NSCLC

Updated Category News Views 7

Dissecting the Nuances of the EVOKE-03/KEYNOTE-D46 Trial Every once in a while, we come across a trial that rattles cages in the research community. Today, it's the EVOKE-03/KEYNOTE-D46 trial, a collision of hope and hard-knock reality. This Phase 3 trial, which sought to explore the potential combo of sacituzumab govitecan (SG) and pembrolizumab on metastatic non-small...

Continue Reading
PwC US and India Unite for Global Consultancy Powerhouse

Updated Category News Views 6

Rearranging the Consultancy Chessboard Piling onto the game of consultancy realignments, PwC just made a move reminiscent of playing strategy poker. They're tossing together PwC US and PwC India's advisory capabilities for a new joint venture. It’s like pushing two puzzle pieces to make a single colorful picture that stretches from the U.S. all the way to the...

Continue Reading
Regeneron Faces Legal Heat: Lead Plaintiff Deadline Looms

Updated Category News Views 0

Regeneron’s Tight Spot: Legal Showdown Well, here we go again—Regeneron Pharmaceuticals (NASDAQ:REGN) is under some serious heat. If you're an investor who faced significant losses with this biotech juggernaut, remember that the clock’s ticking down to the wire. By tomorrow, September 14, 2026, you need to decide if you're going to throw your hat in the ring for...

Continue Reading
Ris-Rez May Set New Standard in Relapsed SCLC

Updated Category News Views 4

The Game-Changing Results Innovation in pharmaceuticals sometimes feels like a waiting game, but when a fresh breakthrough like this rolls in, it lights up the whole landscape. Risvutatug rezetecan, or Ris-Rez for short, has shown promising potential in the fight against relapsed small-cell lung cancer (SCLC) that has progressed after platinum-based therapy. Survival...

Continue Reading
MRI Surveillance Gains Ground in Lung Cancer Care

Updated Category News Views 3

Shifting the Standard: MRI's Rise in SCLC Treatment Here's a twist that baffles the traditionalists—ditch the prophylactic cranial irradiation (PCI) and catch clearer days with MRI surveillance for small-cell lung cancer (SCLC). The latest international phase III MAVERICK trial might just redraw the lines on what's considered standard care in this relentless disease....

Continue Reading

Top 5 Most Recently Viewed Articles

Conformal Coatings Market Set for Significant Growth by 2032

Updated Category News Views 233

The conformal coatings market surged ahead with projections showing it could reach USD 1.7 billion by 2032. This translates into a compound annual growth rate (CAGR) of 5.7% from 2024 to 2032, driven primarily by advancements in electronic protection technologies. Traders had better keep their eyes peeled—this ain't just a bump; it's a substantial shift. What’s...

Continue Reading
Japanese Mobile Battery Industry Forecasts Significant Growth

Updated Category News Views 122

Japan Mobile Battery Market Overview The mobile battery market in Japan is witnessing significant growth, with a valuation of JPY 207.96 billion in 2024 and projected to escalate to JPY 358.97 billion by 2033, marking a compound annual growth rate (CAGR) of 6.48% from 2025 to 2033. This growth trajectory highlights not only increasing consumer demands but also rapidly...

Continue Reading
Givastomig: A Promising Player in Gastric Cancer Therapy

Updated Category News Views 74

Givastomig's Advances in Gastric Cancer Research I-Mab (NASDAQ: IMAB), a biotech firm focused on developing cancer immunotherapies, recently presented exciting results from its Phase 1 clinical trial involving givastomig. This innovative bispecific antibody immunostimulant was unveiled at a prominent medical conference, demonstrating its effectiveness in treating advanced...

Continue Reading
Rani Therapeutics Partners with Chugai for Drug Delivery Breakthrough

Updated Category News Views 245

Rani Therapeutics Engages with Chugai Pharmaceutical Rani Therapeutics Holdings, Inc. (NASDAQ: RANI) recently announced a significant collaborative effort with Chugai Pharmaceutical Co., Ltd., resulting in an enthusiastic response from investors. This collaboration aims to utilize Rani's innovative RaniPill oral drug delivery system alongside Chugai's experimental...

Continue Reading
Revizto's Brand Revamp: A Bold Step Towards Future Growth

Updated Category News Views 142

Revizto Introduces a Fresh Brand Identity As project complexities continue to rise in the construction industry, Revizto is making important modifications to its public image. The renowned collaboration platform, specifically designed for the Architecture, Engineering, Construction, and Operations (AECO) sectors, recently unveiled its refreshed brand identity,...

Continue Reading